Supernus Pharmaceuticals Inc (SUPN)
CapEx to Revenue
0.26%
Quarterly · Period ending:
SUPN CapEx to Revenue
Latest reported0.26%period ending
Latest reported0.26%period ending
SUPN Quarterly CapEx/Revenue (-3.92% → 0.26%)
Latest values, visible window
High-resolution chart · PNG
SUPN capex to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | CapEx to Revenue |
|---|---|
| 0.2593% | |
| 0% | |
| 0.2018% | |
| 0.0672% | |
| 0.275% | |
| 0.2183% | |
| 0.1223% | |
| 0.1138% | |
| 0.038% | |
| 0.1726% | |
| 0.0219% | |
| 0.0975% | |
| 0.1173% | |
| 0.1808% | |
| 0.5146% | |
| 0.0829% | |
| 0.3387% | |
| 0.558% | |
| 0.0251% | |
| 0.0296% | |
| 0% | |
| 1.1517% | |
| 0.1498% | |
| 0.1044% | |
| 0.4222% | |
| 2.6712% | |
| 2.02% | |
| 0.4523% | |
| 0.0229% | |
| 0.2586% | |
| 0.0828% | |
| 0.1854% | |
| 0.3054% | |
| 0.2798% | |
| 0.8549% | |
| 0.5236% | |
| 0.728% | |
| 0.5211% | |
| 0.4826% | |
| 0.7023% | |
| 1.2376% | |
| 0.6477% | |
| 2.0256% | |
| 1.1999% | |
| 1.6775% | |
| 0.6718% | |
| 9.8406% | |
| 2.292% | |
| 3.7136% | |
| 14.5248% | |
| 6.1061% | |
| 54.3357% | |
| 236.6548% | |
| 253.0612% | |
| 18.3486% | |
| 431.8681% | |
| 131.8681% | |
| 19.2308% | |
| -1.9401% | |
| 709.0909% | |
| 28.4% | |
| 0% | |
| -0.4054% | |
| 0% | |
| -3.9217% |